IGF1 and Hyperinsulinemia: Hyperinsulinemia reduces the levels of IGF-binding proteins (IGFB1 and IGFB2), leading to higher free IGF-1 bioavailability, which in turn promotes mitogenesis and inhibits apoptosis in endometrial cells.